High circulating vascular endothelial growth factor (VEGF) is related to a better systolic function in diabetic

Gianluca Iacobellis1, Rosalba Cipriani, Annarita Gabriele

  • 1Endocrinology, Department of Clinical Sciences, La Sapienza University, Rome, Italy. gianluca.iaco@tin.it

Cytokine
|June 23, 2004
PubMed

Insights

High vascular endothelial growth factor (VEGF) levels correlate with better heart function in diabetic hypertensive patients. VEGF may improve cardiac performance in diabetes, despite cardiac remodeling.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Neovascularization Biology

Background:

  • Vascular Endothelial Growth Factor (VEGF) is implicated in cardiac microcirculation.
  • Limited data exist on VEGF's impact on cardiac function and morphology in diabetic patients.
  • This study investigates VEGF's influence on cardiac performance in type 2 diabetic hypertensive individuals.

Purpose of the Study:

  • To test the hypothesis that circulating VEGF levels affect cardiac performance in patients with type 2 diabetes and hypertension.
  • To explore the relationship between VEGF levels and cardiac structure and function in this population.

Main Methods:

  • Study included 30 patients with type 2 diabetes and hypertension, and 10 hypertensive non-diabetic controls.
  • Exclusion criteria: severe cardiac, retinal, renal, or peripheral vascular damage.
  • VEGF plasma levels were measured using ELISA, and echocardiographic parameters were assessed.

Main Results:

  • Diabetic patients exhibited significantly higher VEGF plasma levels compared to controls (median 82 vs. 50.5 pg/mL, p=0.05).
  • VEGF levels correlated with relative wall thickness (RWT) and systolic parameters in diabetic patients.
  • RWT and ejection fraction (EF) were identified as independent correlates of VEGF (r²=0.274, p=0.03 and p=0.05, respectively).

Conclusions:

  • Elevated VEGF plasma levels are associated with improved systolic function in diabetic hypertensive patients with cardiac remodeling.
  • VEGF may play a beneficial role in enhancing cardiac performance in the context of diabetes.
Abstract

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...